Sutro Biopharma, Inc. STRO
Regular-session close
After hours · Nov 19, 4:26 PM ET
- YTD
- -24.63%
- 1 year
- -4.18%
STRO free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-178,926,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -178,926,000 | 15,712,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -194,638,000 | -78,707,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -115,931,000 | -111,622,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -4,309,000 | 92,693,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -97,002,000 | -22,071,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -74,931,000 | -6,427,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -68,504,000 | -79,630,000 | -715.71% |
| FY 2018 | 2018-12-31 | 11,126,000 | 51,515,000 | Not meaningful |
| FY 2017 | 2017-12-31 | -40,389,000 | -22,858,000 | Not meaningful |
| FY 2016 | 2016-12-31 | -17,531,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:16.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
